Careers  |  Sign In  |  Register  |   Twitter

Latest in Family Medicine

According to CBS News, the FDA advisory panel has voted to recommend flibanserin, which is also being called, the “female viagra”. Sprout Pharmaceuticals, the developer of the drug, states that flibanserin is a non hormonal drug that acts as a 5HT1A agonist and 5HT2A antagonist and is classified as a...
Each week, The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related matters.
An experimental women’s libido drug, flibanserin, developed by Sprout Pharmaceuticals, has been advised for rejection by the FDA advisory panel, according to Reuters. Flibanserin is a selective serotonin reuptake inhibitor (SSRI) and was initially tested as an antidepressant. After it was found to be an...